These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases]. Novikova LS; Arabidze GG Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193 [No Abstract] [Full Text] [Related]
5. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479 [TBL] [Abstract][Full Text] [Related]
6. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Kjeldsen SE; Julius S Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303 [TBL] [Abstract][Full Text] [Related]
7. [The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors]. Greminger P; Vetter W Schweiz Rundsch Med Prax; 1988 Jun; 77(24):673-9. PubMed ID: 3041532 [No Abstract] [Full Text] [Related]
8. [Effects of angiotensin receptor inhibitors on cardiovascular endpoints--current and future evidence]. Karlócai K Orv Hetil; 2003 May; 144(18 Suppl 1):901-3. PubMed ID: 12785235 [TBL] [Abstract][Full Text] [Related]
9. New therapeutic prospects of renin-angiotensin system inhibition. Corvol P Clin Exp Hypertens A; 1989; 11 Suppl 2():463-70. PubMed ID: 2691125 [TBL] [Abstract][Full Text] [Related]
10. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension]. Abassi Z; Armaly Z; Nakhoul F; Hoffman A Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632 [TBL] [Abstract][Full Text] [Related]
11. Benefits of angiotensin converting enzyme inhibition and angiotensin II receptor antagonists in hypertension. Conlin PR J Med Liban; 2000; 48(6):382-6. PubMed ID: 11503531 [TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting-enzyme inhibitors in the treatment of hypertension. Coats AJ Br J Hosp Med; 1987 Dec; 38(6):531-2, 536-41. PubMed ID: 2829986 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular considerations in hypertension: effects of the angiotensin system. A seminar in print. Drugs; 1990; 39 Suppl 1():1-79. PubMed ID: 2307105 [No Abstract] [Full Text] [Related]
14. Fetopathy associated with exposure to angiotensin converting enzyme inhibitors and angiotensin receptor antagonists. Quan A Early Hum Dev; 2006 Jan; 82(1):23-8. PubMed ID: 16427219 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension. Krut LH N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846227 [No Abstract] [Full Text] [Related]
16. Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation. Rockx MA; Haddad H Curr Opin Cardiol; 2007 Mar; 22(2):128-32. PubMed ID: 17284992 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension. Pickering TG N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12840099 [No Abstract] [Full Text] [Related]
18. Angiotensin-converting-enzyme inhibitors and diuretics for hypertension. Esnault VL N Engl J Med; 2003 Jul; 349(1):90-3; author reply 90-3. PubMed ID: 12846229 [No Abstract] [Full Text] [Related]
19. [Comparison of angiotensin receptor antagonists and angiotensin converting enzyme inhibitors in arterial hypertension]. Krezsinski JM; Sternon J Rev Med Brux; 2000 Jun; 21(3):170-7. PubMed ID: 10925600 [TBL] [Abstract][Full Text] [Related]
20. Future directions in cardiovascular pharmacology: examples from the Renin-Angiotensin system. Diz DI Mol Interv; 2008 Oct; 8(5):222-5. PubMed ID: 19015385 [No Abstract] [Full Text] [Related] [Next] [New Search]